Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


freedom959.net > 09/14/2026 > lilly-says-foundayo-has-captured-over-30-of-new-us-patients-on-oral-weight-loss-drugs

Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs

15+ min ago   (323+ words) Sept 14 (Reuters) – Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early ​lead gained by Danish rival Novo Nordisk with its ‌Wegovy pill. Novo CEO Mike…...


medpagetoday.com > neurology > generalneurology > 122994

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

1+ hour, 37+ min ago   (7+ words) Motor function may improve with adjunctive apitegromab...


pymnts.com > healthcare > 2026 > modernas-ai-built-cancer-vaccine-clears-phase-3-with-merck

Moderna???s AI-Built Cancer Vaccine Clears Phase 3 With Merck

46+ min ago   (126+ words) Moderna’s AI reads a patient’s own tumor, decides which mutations to target and builds a treatment that exists nowhere else. The therapy delivered the first positive Phase 3 result for a cancer treatment designed for a single patient. The real challenge…...


medcitynews.com > 2026 > 09 > scholar-rock-drug-wins-first-in-class-approval-in-rare-neuromuscular-disease

Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease

1+ hour, 25+ min ago   (308+ words) Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other…...


markets.businessinsider.com > news > stocks > immunocore-announces-achievement-of-target-enrollment-in-registrational-tebe-am-trial-with-kimmtrak-tebentafusp-in-previously-treated-advanced-melanoma-1036542517

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

20+ hour, 53+ min ago   (302+ words) Topline overall survival data expected as early as end of 2026 "Achieving target enrollment in TEBE-AM is an important milestone for Immunocore and a critical step toward addressing the substantial unmet need in previously treated, post-PD1 advanced melanoma, a setting with…...


religionclause.blogspot.com > 2026 > 09 > in-covid-vaccine-case-9th-circuit.html

In Covid Vaccine Case, 9th Circuit Concurrence Argues for Overruling Smith v. Employment Division

16+ hour, 48+ min ago   (215+ words) In Lewis-Williams v. San Francisco Bay Area Rapid Transit District, (9th Cir., Sept. 11, 2026), the U.S. 9th Circuit Court of Appeals upheld a jury's verdict against the Bay Area Rapid Transit District (BART). The jury found BART failed to show that accommodating employees' religious objections…...


news.northeastern.edu > 09/14/2026 > new-cancer-vaccine-oxygen-t-cells

This cancer vaccine makes its own oxygen and gives T-cells a boost

1+ hour, 59+ min ago   (890+ words) A new cancer vaccine developed by Northeastern researchers creates a home base to educate immune cells about the enemy. It also gives the immune system “breathing room” by providing an oxygen boost at the injection site. When it comes to…...


statnews.com > 09/11/2026 > pro-vaccine-advocacy-celebration-party

I’m a public health communications consultant. Pro-vaccine advocacy needs more fun

3+ day, 19+ hour ago   (824+ words) On April 12, 1955, America threw a vaccine party. That morning, Thomas Francis Jr. — who had overseen trials of polio vaccines developed by Jonas Salk — held a press conference to announce the results. Only it wasn’t a press conference. It was an…...


medicaldialogues.in > pulmonology > news > vtd-shows-potential-to-modify-cystic-fibrosis-progression-in-young-children-study-179213

VTD Shows Potential to Modify Cystic Fibrosis Progression in Young Children: Study

5+ hour, 7+ min ago   (54+ words) Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit Overcoming the Challenge of Maintaining Weight Reduction Sympathetic Overactivity: The Driver of Hypertension in Young Indians India's Medical Startups: From Innovation to Impact - Prof. (Dr) Yogendra Kumar…...


statnews.com > 09/14/2026 > rfk-speech-childrens-health-defense-conference-washington

Kennedy to deliver keynote for anti-vaccine group he once led

2+ hour, 58+ min ago   (303+ words) WASHINGTON — Health Secretary Robert F. Kennedy Jr. will give a keynote address at a Children’s Health Defense conference in the nation’s capital this week, embracing the anti-vaccine organization he once led. “We couldn’t be more excited to welcome our founder…...